Literature DB >> 29755923

Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.

Bryan M McClarty1, Daniel W Fisher2, Hongxin Dong1.   

Abstract

PURPOSE OF THE REVIEW: Antipsychotics are commonly prescribed for the treatment of psychosis as well as behavioral and psychological symptoms of dementia (BPSD) in elderly patients. However, elderly patients often experience decreased antipsychotic efficacy and increased side effects, though the mechanisms underlying these changes with age are not clear. RECENT
FINDINGS: Although aging can affect drug metabolism and clearance through changes in renal and hepatic function, additional pharmacokinetic and pharmacodynamic changes due to aging-induced epigenetic alterations also impact processes important for antipsychotic function. Epigenetic mechanisms account for some of the altered efficacy and increased side effects seen in elderly patients.
SUMMARY: Both clinical and animal studies from our group and others have demonstrated a plausible epigenetic mechanism involving histone modifications that can adversely affect the efficacy of antipsychotics and increase their side effects in elderly patients. Hopefully, further investigation of this mechanism will benefit elderly patients who need treatment for psychosis and BPSD.

Entities:  

Keywords:  Aging; Antipsychotics; Drug efficacy; Epigenetics; Histone modification; Side effects

Year:  2018        PMID: 29755923      PMCID: PMC5943049     

Source DB:  PubMed          Journal:  Curr Treat Options Psychiatry


  74 in total

Review 1.  Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

Authors:  Peter Aupperle
Journal:  Am J Alzheimers Dis Other Demen       Date:  2006 Mar-Apr       Impact factor: 2.035

2.  Treatment patterns and characteristics of older antipsychotic users in Germany.

Authors:  Niklas Schmedt; Kathrin Jobski; Bianca Kollhorst; Jutta Krappweis; Eckart Rüther; Tania Schink; Edeltraut Garbe
Journal:  Int Clin Psychopharmacol       Date:  2016-05       Impact factor: 1.659

3.  Epigenetic transgenerational actions of endocrine disruptors and male fertility.

Authors:  Matthew D Anway; Andrea S Cupp; Mehmet Uzumcu; Michael K Skinner
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

Review 4.  Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.

Authors:  Daniel Tarsy; Codrin Lungu; Ross J Baldessarini
Journal:  Handb Clin Neurol       Date:  2011

5.  Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.

Authors:  Janitza L Montalvo-Ortiz; Daniel W Fisher; Guadalupe Rodríguez; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Psychopharmacology (Berl)       Date:  2017-04-18       Impact factor: 4.530

Review 6.  Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.

Authors:  Nilkantha Sen
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

7.  Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease.

Authors:  Yasuhiro Tanaka; Kenichi Meguro; Satoshi Yamaguchi; Hiroshi Ishii; Shoichi Watanuki; Yoshihito Funaki; Keiichiro Yamaguchi; Atsushi Yamadori; Ren Iwata; Masatoshi Itoh
Journal:  Ann Nucl Med       Date:  2003-10       Impact factor: 2.668

8.  Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.

Authors:  N Kemppainen; M Laine; M P Laakso; V Kaasinen; K Någren; T Vahlberg; T Kurki; J O Rinne
Journal:  Eur J Neurosci       Date:  2003-07       Impact factor: 3.386

9.  Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum.

Authors:  Kenji Ishibashi; Kenji Ishii; Keiichi Oda; Keiichi Kawasaki; Hidehiro Mizusawa; Kiichi Ishiwata
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

Review 10.  Epigenetic determinants of healthy and diseased brain aging and cognition.

Authors:  Schahram Akbarian; Michal Schnaider Beeri; Vahram Haroutunian
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

View more
  2 in total

Review 1.  The Hyperactivity-Impulsivity-Irritiability-Disinhibition-Aggression-Agitation Domain in Alzheimer's Disease: Current Management and Future Directions.

Authors:  Rachel M Keszycki; Daniel W Fisher; Hongxin Dong
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

2.  Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice.

Authors:  Bryan McClarty; Guadalupe Rodriguez; Hongxin Dong
Journal:  Front Neurosci       Date:  2021-10-06       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.